BSS S.A. offers comprehensive business process services, including outsourcing of accounting and reporting services, consolidation of financial statements, outsourcing of HR and payroll services, management accounting, tax services, support of financing processes, and business advisory services. The company is a member of the Association of Business Service Leaders (ABSL).
Currently, BSS provides services to more than 240 Polish and foreign entities, with a growing share of third-party clients (over 30% at the end of 2015). The BSS staff comprises first-rate specialists including chartered auditors, ACCA-certified accountants and tax advisors with international experience in BPO centres and consulting firms.
The primary focus of BSS, a provider of comprehensive finance and accounting services, is on delivering effective solutions. The BSS team acts as an individual adviser to business clients, providing them with end-to-end support: from bookkeeping, to financial reporting based on Polish and international standards, HR and payroll, through to advanced management accounting, support in finance raising, tax advice and business consultancy − always tailoring its range of services to the expectations of each client.
In 2015, the company continued to implement its LEAN-based operational excellence initiative and developed electronic archives for documents generated in the procurement process. A strong focus was placed on understanding the business processes of clients and boosting their performance through jointly run projects. “BUSINESS PARTNERSHIP built on trust and quality with a view to providing professional support to further your business success” is the BSS mission statement, pursued daily through the three pillars of comprehensive service, proven team and process quality. The company meets regularly with business leaders to share its knowledge of various aspects of corporate finance. The Business Inspiration events held in 2015 were addressed to businesses operating within the Łódź Special Economic Zone. The year also saw a range of new business education initiatives, including the ‘7 myths of outsourcing’ webinar and provision of expert input to the ‘Modern CFO’ industry report.
Challenges and plans
Going forward, BSS plans to develop by continuing to upgrade its own in-house processes and enhance the business processes of its clients, and setting up teams combining various fields of expertise to deliver solutions facilitating the BSS - client interactions. The company also wants to further expand its BSS scanning centre and build more electronic document archives to reduce the hard copy output.
We seek to be a trusted adviser to all companies struggling to recover their debts which look for transparency, integrity and optimum solutions.
The principal business of CONSENSUS Sp. z o.o. is to provide support to its partners – both Pelion companies and third parties – in credit risk management at all stages of a business relationship: from review of customers’ financial standing and credit histories, through determining the amount of trade credit limits and monitoring the timeliness of payments, to assistance in debt discharge and debt collection procedures.
The company was established in 2001, originally under the name Farm-Serwis Sp. z o.o. In December 2015, in response to growing demand for financial advisory services from the non-pharmaceutical sector, the company began the process of rebranding. Currently, trading under the name Consensus, it shares its professional experience with a growing number of clients.
The Consensus team is composed of legal, debt collection and risk management experts, with a track record of more than 1,000 successful debt collection cases, and debt under management of approximately PLN 300m at the end of 2015.
In 2015, Consensus (at the time still trading under the name of Farm-Serwis) continued to pursue a strategy focusing on detailed credit vetting of new customers and tight risk control with respect to existing accounts.
At the end of 2015, the company managed a PLN 275m (gross) pharmaceutical debt portfolio, of which only PLN 37m was due and payable. The fact that almost half of the receivables are past due by less than seven days must be viewed as the company’s success.
Challenges and plans
In 2016, the company’s rebranding will be continued to step up the acquisition of non-pharmaceutical clients. 2016 will also see the roll-out of new IT systems to streamline the company’s operations, supporting a more accurate risk analysis and more efficient monitoring of customer debts.
epruf is a company connecting healthcare with the insurance market. It is an operator of settlements related to drug insurance and healthcare programmes. For over six years, it has partnered with insurance companies in the administration of drug insurance products. It ensures efficient and convenient settlements between insurance companies and pharmacies, and provides business support services to corporate clients in the field of benefit settlement and analyses.
epruf’s portfolio includes drug insurance products offered by PZU Życie, PZU Zdrowie and LUX MED Ubezpieczenia. At the end of 2015, the company’s services covered more than 500,000 insureds and 30% of pharmacies on the Polish market.
The principal business of Eubioco S.A. is the provision of contract-based manufacturing services, product research and development, and manufacturing activities at Laboratorium Galenowe Olsztyn Sp. z o.o. The company’s customers include domestic and foreign entities building proprietary brands who need a reliable partner with manufacturing standards confirmed by a GMP certificate. Additional services offered by the company include development of process documentation required in the notification procedure for dietary supplements.
In 2015, under its contract-based manufacturer strategy, the company strengthened relationships with its existing partners by offering them a wider range of products, and also acquired new customers and new products for its manufacturing plant, doubling the output.
ALE Sp z o.o. is a manufacturer of dietary supplements for both amateur and professional sportsmen, with product safety and top quality confirmed by GMP and HACC certificates. At the end of 2015, the company had 30 SKUs within three product lines: Energy, Health and Power. ALE products are widely available – in pharmacies, food supplement shops, fitness clubs, FMCG outlets, as well as online. Currently, about 95% of sales take place outside pharmacies.
Pharmena S.A. is a biotechnology company which develops and commercialises state-of-the-art products based on 1-MNA − its patented active ingredient. Since 2008, it has been listed in the alternative trading system on the NewConnect market. Currently, the company focuses on two projects using 1-MNA: launch of an innovative food supplement and clinical trials of an anti-atherogenic drug. In 2015, Pharmena received the UK Food Standards Agency’s authorisation to market the dietary supplement and successfully completed the 2nd stage of clinical trials of the experimental anti-atherogenic drug. So far, it has introduced nearly 30 dermocosmetics distributed through pharmacies and beauty stores. One of these products – Dermena – is a leading brand in its category in terms of the number of products sold on the Polish market (with a 26% market share). In December 2015, as a result of purchase of additional shares, Pelion took control of Pharmena S.A., which previously had the status of an associate.
The Brzeziny Specialist Hospital provides top quality medical services, mainly under contracts with the National Healthcare Fund (NFZ), and also on commercial terms. The hospital specialises in the treatment of colonic diseases; in 2015, it performed over 500 surgical procedures for colorectal cancer. It offers a number of innovative procedures such as colon cancer surgery using a colonoscope, achalasia treatment with a gastroscope, using a neurostimulant and liquid cartilage. It is one of few hospitals in the region offering a fast and comprehensive cancer therapy. In 2015, the hospital was accredited by the Ministry of Health’s Centre for Monitoring Healthcare Quality.
Daruma Sp. z o.o.
The company’s principal business is the lease of property, plant and equipment and property management across the Pelion Group.
Pharmauto Sp. z o.o.
The company manages Pelion’s vehicle fleet.
Pharma Partner Sp. z o.o.
The company’s focus is on the design and development of innovative healthcare solutions in response to patients’ needs.
Bez Recepty Sp. z o.o.
The principal business of Bez Recepty Sp. z o.o. is publishing.